they seem to be working along the same lines as sla, they recently 8/7/08 ceased work on phase 2a trials saying total norminalisation was not achieved and further formulation is warranted. they went into th today. sla has better results has pharma approval in russia for ropren and the sp is cheaper, whats it gonna take to get the monkey of our back. they are workin on hep c with genotype 1 ,does ropren work on this anyone know.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
19.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $11.25M | |||
| Open | High | Low | Value | Volume |
| 18.5¢ | 19.0¢ | 18.0¢ | $9.954K | 54.46K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 134 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.5¢ | 12933 | 1 |
View Market Depth
| Last trade - 13.46pm 18/09/2025 (20 minute delay) ? |
| SLA (ASX) Chart |